ArticleFrontiers in immunology2026
Early creatinine dynamics for stratifying acute kidney injury trajectories in patients with systemic lupus erythematosus: an exploratory multicenter retrospective study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Patients with systemic lupus erythematosus (SLE) exhibit heterogeneous renal courses after acute kidney injury (AKI). This study applied latent class mixed modeling to identify AKI trajectory phenotypes in SLE, developed a risk-stratification model using early post-AKI data, and explored whether hydroxychloroquine (HCQ) use is associated with AKI trajectory class membership. Methods: This multicenter retrospective study used MIMIC-IV for model development and internal assessment and eICU, NWICU, and local cohorts for exploratory external assessment. Adult SLE patients with AKI were included. The primary model was a race-free, no-imbalance-correction LASSO logistic regression model. Performance was assessed with AUC, Brier score, calibration intercept, and calibration slope. Bootstrap optimism correction was applied. A non-overlap sensitivity analysis examined the influence of structural predictor-outcome overlap. HCQ was evaluated using multivariable logistic regression and propensity score matching. Results: Among 279 MIMIC patients, three AKI trajectories were identified (progressive 9.3%, recovery 19.4%, stable 71.3%). The primary race-free LASSO model achieved an apparent AUC of 0.761 (optimism-corrected: 0.706) and a Brier score of 0.086 (corrected: 0.092). When assessed against a non-overlapping post-48-hour renal endpoint, discrimination diminished substantially (AUC 0.593). Exploratory external assessments were event-limited: the main SLE external discrimination subsets contained 6 events in eICU, 3 events in NWICU, and 1 event in the local cohort; therefore, these estimates were considered descriptive rather than definitive validation. HCQ showed an exploratory association not interpretable as causal. Conclusion: This study provides an exploratory risk-stratification framework for early AKI trajectory patterns in SLE. The apparent discrimination was substantially attenuated after removing predictor-outcome overlap and adjusting for optimism. External assessments were event-limited and should be interpreted as exploratory transportability assessments rather than definitive evidence of generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.